期刊文献+

益肾通络方对C-BSA肾病综合征大鼠模型的整体治疗作用 被引量:5

Pharmacodynamic Study of Yishen Tongluo in Rats with Nephrotic Syndrome by C-BSA
下载PDF
导出
摘要 目的:观察益肾通络方对阳离子牛血清白蛋白(C-BSA)大鼠模型的整体治疗作用。方法:采用C-BSA复制肾病综合征大鼠模型,随机分为3组,即模型组,肾炎四味片组,益肾通络方组,每组各10只,并以10只同批正常大鼠为正常组。分别测定大鼠24h尿蛋白,血清白蛋白,血肌酐,血尿素氮;观察大鼠肾组织病理形态,测定面积比。结果:益肾通络方组24h尿蛋白含量、血清肌酐、血尿素氮下降(P<0.01);血清白蛋白提高(P<0.01);肾脏病理损害均有不同程度减轻,面积比减少(P<0.01);其作用优于模型组和肾炎四味片组(P<0.05,P<0.01)。结论:益肾通络方对肾病综合征大鼠有良好的治疗作用,能改善相关蛋白,改善肾功能,减轻肾脏病理损害。 Objective: To study the holistic effect of Yishen Tongluo on treating rats with nephrofic syndrome (NS). Methods :50 rat models made by cationic bovine serum album/n( C - BSA) were devided into five groups at random,including the pathological pattern group, the control group (Shenyan Siwei Pian, SYSW) and Yishen Tongluo (YSTL) group. Each experimental group consisted of 10 rats and the normal group contained 10 normal rats in the same batch. All rots were examined 24 hours later for urine protein quantity (24huPro) ,albumin(Alb) ,serum creatinine(Scr) and blood urea nitrogen(BUN). Their pathological forms were also observed and positive area ratio examined. Results: In YSTL goup, the 24huPro, Scr and BUN decreased ( P 〈 0. 01 ), while Alb increased(P 〈0. 01 ). Also,in YSTL group,the pathological damage, positive area ratio decreased in kidney( P 〈0. 01 ). It was much better than either the pathological pattern group or SYSW one respectively(P 〈 0. 05,P 〈 0. 01 ). Conclusion:YSTL had obvious effects on rats with NS. It could improve the relative proteins and the functions of kidney, and reduce the pathological damages.
出处 《辽宁中医杂志》 CAS 北大核心 2008年第10期1597-1600,共4页 Liaoning Journal of Traditional Chinese Medicine
基金 湖南省教育厅重点资助科研项目(07A037) 湖南省科学技术计划资助项目(医060260)
关键词 益肾通络方 肾病综合征 治疗作用 Chinese herbal formula( Yishen Tongluo) Nephrotic syndrome Treatment
  • 相关文献

参考文献8

二级参考文献63

共引文献231

同被引文献29

  • 1陈奇.中药药理研究方法学[M].北京:人民卫生出版社,1994.480.
  • 2国家药典委员会.中国药典[M].北京:化学工业出版社,2005,1..
  • 3贺石林.中医科研设计与统计学[M].长沙:湖南科学技术出版社,2003.38.
  • 4国家药典委员会.中国药典(2010版,第1部).北京:中国医药科技出版社,2010.
  • 5李玉林.病理学[M].8版.北京:人民卫生出版杜,2013:129-132.
  • 6国家食品药品监督管理局.中药、天然药物长期毒性试验技术指导原则[S].2005.
  • 7卢岳华,陈小光,金红,汪保和.补肾通络方治疗肾病综合征的临床观察[J].湖南中医药大学学报,2007,27(6):47-49. 被引量:10
  • 8BORDER WA,WARD HJ,KAMIL ES,et al.Induction of membranous nephropathy in rabbits by administration of an exogenous cationie antigen[J].J Clin Invest,1982,69(2):451-461.
  • 9NAHAS AM,MUCHANETA KUBARA EC,ESSAWY M,et al.Renal fibrosis:insights into pathogenesis and treatment[J].Int J Biochem Cell Biol,1997,29(1):55-62.
  • 10BAUD L,FOUQUERAY B,BELLOCQ A.Inflamatory mechanisms of renal fibrosis:glomerulonephritis[J].Bull Acad Natl Med,1999,183(1):23-31.

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部